MedX Health Corp (USD) MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

MedX Health Corp (USD) Active

1495 Bonhill Road, Mississauga, ON, CA, L5T 1M2

Stock Price USD

Price Change

Last Dividend USD

MDXHF's stock peer is BCCOY (BICO Group AB (publ))

MDXHF's stock peer is BNVIF (Binovi Technologies Corp.)

MDXHF's stock peer is CLLKF (BICO Group AB (publ))

MDXHF's stock peer is DMTRF (3-D Matrix, Ltd.)

MDXHF's stock peer is IMPZY (Implanet S.A.)

MDXHF's stock peer is JUSHF (Jushi Holdings Inc.)

MDXHF's stock peer is PXMBF (Paxman AB (publ))

MDXHF's stock peer is RCEL (AVITA Medical, Inc.)

MDXHF's stock peer is RQHTF (Reliq Health Technologies Inc.)

MDXHF's stock peer is VMTHF (Venus Medtech (Hangzhou) Inc.)

Healthcare Medical - Devices

MedX Health Corp, a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, and internationally. The company offers SIAscopy, a medical device technology used to scan skin for suspicious moles and lesions; phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market; and SIAMETRICS, SIMSYS, and MoleMate, which creates real-time images for physicians and dermatologists to evaluate various types of moles or lesions within seconds. It operates DermSecure telemedicine platform that enables the web-based operation of its SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion images along with other relevant patient information can be connected to specialist physicians for remote assessment. The company was incorporated in 1999 and is headquartered in Mississauga, Canada.

Income Statement

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Recent News

MedX announces Initial Closing and Proposed Extension of Non-Brokered Private Placement

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX announces Initial Closing and proposed Extension of Offering.

2025-10-03 19:33:00

MedX Health Appoints Dr. Symon Cotton as Strategic Advisor on AI & Product Development

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), (“MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Symon D. Cotton, accomplished medical device innovator and co-developer of SIAscopy®, as Strategic Advisor to the Company. Dr. Cotton is an experienced author and leader in medical technology innovation, currently serving as Head of Life Sciences at a leading technology organization. His career.

2025-09-25 21:16:00

MedX Health Appoints Global Skin Science Leader Dr. Paul Matts as Strategic Advisor

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (TSXV: MDX), “MedX” or the “Company”), a global leader in teledermatology and non-invasive skin analysis, today announced the appointment of Dr. Paul J. Matts, internationally recognized skin scientist, biochemist and educator, as Strategic Advisor to the Company. Dr. Matts joined Procter & Gamble (P&G) in 1988 as a PhD biochemist and then spent more than three decades in the company's Research & Development (R&D) division.

2025-09-08 20:20:00

MedX Announces Proposed Extension of Non-Brokered Private Placement

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced today that, subject to acceptance by the TSX-V, the ultimate Closing Date for the non-brokered Private Placement of up to $2.5 million, which was previously announced on July 25, 2025, will be extended by up to 30 days. The Company has already received Conditional Acceptance for the placement from the TSX-V, but closing for the full amount of the proposed Placement has been delayed. The pro.

2025-09-08 19:53:00

MedX Health Corp. Names Meghan Geary as Senior Vice President of Operations

MISSISSAUGA, Ontario--(BUSINESS WIRE)--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), the global leader in teledermatology solutions, confirms the appointment of Meghan Geary as the Company's Senior Vice President of Operations, effective immediately. With over 10 years experience in building scalable programs across SaaS and high-growth healthcare companies, Geary will oversee strategic operations, drive organization performance, and support MedX's continued growth trajectory. "I'm e.

2025-08-20 20:28:00

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions